Accepted for Publication: July 27, 2020.
Published: September 30, 2020. doi:10.1001/jamanetworkopen.2020.19801
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2020 Ro R et al. JAMA Network Open.
Corresponding Author: Stamatios Lerakis, MD, PhD, Division of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, One Gustave L. Levy Place, New York, NY 10029 (email@example.com).
Author Contributions: Drs Ro and Lerakis had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Khera, Kini, Lerakis.
Acquisition, analysis, or interpretation of data: Ro, Khera, Tang, Krishnamoorthy, Sharma, Lerakis.
Drafting of the manuscript: Ro, Krishnamoorthy, Lerakis.
Critical revision of the manuscript for important intellectual content: Khera, Tang, Sharma, Kini.
Statistical analysis: Krishnamoorthy, Lerakis.
Administrative, technical, or material support: Khera, Tang, Sharma.
Supervision: Khera, Tang, Kini, Lerakis.
Conflict of Interest Disclosures: Dr Khera reported being a consultant for Abbott, Medtronic, and Boston Scientific, and receiving speakers’ honoraria from Medtronic. Dr Tang reported being a physician proctor for Medtronic and a consultant for Medtronic, Abbott Structural Heart, and W. L. Gore & Associates. No other disclosures were reported.
Additional Contributions: Malcolm Anastasius, MBBS, PhD (Mount Sinai Hospital), provided assistance with data analysis; he was not compensated for this work.
PB , Welt
FGP , Mahmud
et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC /SCAI position statement. JACC Cardiovasc Interv
. 2020;13(12):1484-1488. doi:10.1016/j.jcin.2020.04.001PubMedGoogle ScholarCrossref